We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JAMF
3051
DELISTED
Jamf
JAMF
$115K ﹤0.01%
+3,049
New +$114K
VATE icon
3052
INNOVATE Corp
VATE
$106M
$115K ﹤0.01%
4,759
+4,541
+2,083% +$123K
WHG icon
3053
Westwood Holdings Group
WHG
$185M
$115K ﹤0.01%
10,294
+2,191
+27% +$26.9K
RESN
3054
DELISTED
Resonant Inc.
RESN
$115K ﹤0.01%
48,249
+15,602
+48% +$38.9K
BLDP
3055
Ballard Power Systems
BLDP
$820M
$114K ﹤0.01%
7,594
-6,050
-44% -$97.4K
FRAF icon
3056
Franklin Financial Services
FRAF
$287M
$114K ﹤0.01%
5,332
+4,169
+358% +$100K
GALT icon
3057
Galectin Therapeutics
GALT
$349M
$114K ﹤0.01%
42,866
+34,304
+401% +$96.1K
GENC icon
3058
Gencor Industries
GENC
$263M
$114K ﹤0.01%
10,381
+6,101
+143% +$74.4K
LOB icon
3059
Live Oak Bancshares
LOB
$2.01B
$114K ﹤0.01%
4,476
+832
+23% +$16.2K
SAGE
3060
DELISTED
Sage Therapeutics
SAGE
$114K ﹤0.01%
1,872
-2,179
-54% -$110K
SAMG icon
3061
Silvercrest Asset Management
SAMG
$78.7M
$114K ﹤0.01%
10,930
-5,016
-31% -$59K
SCWX
3062
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$114K ﹤0.01%
10,027
+8,136
+430% +$98.7K
CNQ icon
3063
Canadian Natural Resources
CNQ
$99.5B
$113K ﹤0.01%
14,486
-168,389
-92% -$1.52M
FATE icon
3064
Fate Therapeutics
FATE
$298M
$113K ﹤0.01%
2,824
-9,295
-77% -$325K
FFWM
3065
DELISTED
First Foundation Inc
FFWM
$113K ﹤0.01%
8,650
+3,803
+78% +$57.7K
FRBA icon
3066
First Bank
FRBA
$469M
$113K ﹤0.01%
18,162
+13,831
+319% +$92.1K
EVBN
3067
DELISTED
Evans Bancorp Inc
EVBN
$113K ﹤0.01%
5,094
+3,894
+325% +$89.3K
IIN
3068
DELISTED
IntriCon Corporation
IIN
$113K ﹤0.01%
9,304
+7,096
+321% +$86.3K
TREE icon
3069
LendingTree
TREE
$458M
$112K ﹤0.01%
365
-1,498
-80% -$476K
SBBP
3070
DELISTED
Strongbridge Biopharma plc.
SBBP
$112K ﹤0.01%
53,463
+44,902
+524% +$151K
AGI icon
3071
Alamos Gold
AGI
$13.9B
$111K ﹤0.01%
12,565
-3,039
-19% -$30.6K
BND icon
3072
Vanguard Total Bond Market
BND
$161B
$111K ﹤0.01%
+1,253
New +$111K
CHMG icon
3073
Chemung Financial Corp
CHMG
$404M
$111K ﹤0.01%
3,828
+3,076
+409% +$87.8K
EGO icon
3074
Eldorado Gold
EGO
$10.3B
$111K ﹤0.01%
10,564
+5,221
+98% +$58.5K
GSIT icon
3075
GSI Technology
GSIT
$268M
$111K ﹤0.01%
19,614
+15,966
+438% +$101K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.